Sinovac Biotech, Ltd. · NASDAQ:SVA
1Globe Capital LLC reported a 32.30% stake in Sinovac Biotech, Ltd. (Schedule 13D/A)
Event Jun 27, 2025 · Filed Jul 3, 2025
1Globe Capital LLC reported a 32.30% stake in Sinovac Biotech, Ltd., 18,515,315 shares, with active intent on Jun 27, 2025. Filed Jul 3, 2025 (Schedule 13D/A).
- Stake
- 32.30%
- Shares
- 18,515,315
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 1Globe Capital LLC | 32.30% | 18,515,315 |
| 1Globe Biomedical (Hong Kong) Company Limited | 32.30% | 18,515,315 |
Source
Related
- Sinovac Biotech, Ltd.
- 1Globe Capital LLC
- Sinovac Biotech, Ltd. shareholders
- Schedule 13D/A · 1Globe Capital LLC · Sep 12, 2025
- Schedule 13D/A · 1Globe Capital LLC · Jul 7, 2025
- Schedule 13D/A · 1Globe Capital LLC · Jul 1, 2025
- Schedule 13D/A · SAIF Partners IV L.P. · Dec 17, 2025
- Schedule 13D/A · Weidong Yin · Jul 15, 2025
- Schedule 13D/A · SAIF Partners IV L.P. · Jul 14, 2025
- Schedule 13D/A · Advantech Capital L.P. · Jul 14, 2025
- Schedule 13D/A · Vivo Capital VIII, LLC · Jul 11, 2025